Interleukin Genetics Inc

(NASDAQ:ILI)

Key Stats & Ratios

Valuation
Market Cap 12.08M
P/E
P/E (Trailing) -1.76
P/E (Forward)
Price/Sales 0.77
Price/Book 1.21
EPS -0.21
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income -6672238.00
Net Income -6683823.00
Profit Margin (ttm) -69.50%
Operating Margin (ttm) -0.69%
Management Effectiveness
Return on Assets (ttm) -50.10%
Return on Equity (ttm)
EBIT Margin (ttm) -68.20
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 5.40M
Revenue 9.61M
Revenue/Share 0.30
Revenue Growth (ytd) -1.20%
Annual Revenue Growth Rate (3Y) 599.84%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 5.19M
EBITDA -4940653.00
Diluted EPS (ttm) -0.21
Balance Sheet
Total Cash 6.04M
Total Cash/Share 0.19
Total Assets 13.35M
Total Liabilities 7.44M
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.68
Current Ratio 2.00
Leverage Ratio 2.00
Book Value/Share 0.19
Cash Flow
Cash Flow -4841160.00
Free Cash Flow -5522352.00
Cash Flow/Share -0.15
Free Cash Flow/Share -0.17

Trading Information

Stock Price History
Beta
52Wk Change -63.50%
52Wk Change Vs. Mkt -45.00%
52Wk High 1.75
52Wk Low 0.13
10 Day Moving Average 0.28
200 Day Moving Average 1.00
Share Statistics
Average Volume 80.20K
Shares Outstanding 31.79M
Shares Float 25.86M
% Held by Insiders 18.70%
% Held by Institutions 5.20%
Shares Short (As of Dec 10, 2008) 40.48K
Short Ratio 1.00
Short % of Float 0.20%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount